Relief Therapeutics Holding AG (RLFTF)

[Uncle Gee Gee]

Hi JTorence... In and of itself, it is somewhat minor news; however, reading further into it, here are a few things I see:


First, this guy isn't cheap... he has a background in clinical trail planning and in laying foundations for product launches. He also has decades of expertise in a number of areas that make him a great fit for Relief.

He will "be responsible for the clinical development of aviptadil in Europe." In other words, they are simultaneously launching efforts in Europe... which is no small task regarding time, money, energy, resources, etc.

As per the chairman: "He will be a great asset to Relief as aviptadil advances in clinical development in Europe and the U.S. and as we hopefully prepare submissions for marketing approval soon."

In the press release, the CMO stated: "aviptadil has broad potential to help patients with other acute and chronic lung diseases", further confirming our expectations of other applications.

This new CMO is basically Europe's version of Dr. Javitt. The clinical trials management company (Virtuoso Sarl) will "set up and run aviptadil clinical trials in Europe", similar to what NeuroRX does here in the US.

So the PR says quite a bit:
1) European efforts (and related expenses) demonstrate Relief's confidence in their product and the progress they are making.
2) It confirms Relief is still expecting US approval soon.
3) It confirms Relief has a vision beyond Covid.
4) It indicates Relief is forming a template for rolling out the drug worldwide... hire a pro to oversee the rollout region, contract with a clinical trials management team, partner with a manufacturer, partner with a distributor.

All great stuff! Certainly no regular OTC-penny-stock-pump.